Skip to content
Search

Latest Stories

RPS, 24 other organisations urge Sajid Javid to retain free prescriptions for over 60s in England

The Royal Pharmaceutical Society (RPS) and 24 other organisations have signed a letter calling for the retention of free prescriptions for patients aged 60 to 66.

It comes after the government announced people in this age group would no longer be exempt from prescription charges.


The letter, addressed to health secretary Sajid Javid, has been signed by 25 organisations from across Great Britain, including the Royal College of General Practitioners, the British Geriatrics Society and Age UK.

It urges the government to rethink its proposal to raise the qualifying age for free prescriptions in England from 60 to 66.

RPS English Pharmacy Board chair Thorrun Govind said: “It is unacceptable to raise the cost of prescriptions in the current economic situation when many have been disadvantaged by the pandemic. Such proposals will only further drive the health inequalities that have been highlighted by Covid-19.

“RPS would like to see the complete abolishment of prescription charges in England, whatever the age group, as is the case in Scotland and Wales.”

The letter highlighted that the government’s proposal would have a lasting adverse impact on the half of 60-64yr olds with one or more long term conditions.

The Department of Health and Social Care (DHSC) has estimated annual savings of £198-£257 million for the NHS as a whole, which is a tiny fraction of the NHS £212.1 billion budget for 2020-21, the letter stated.

According to Age UK, each year, tens of thousands of people may require hospital treatment, having cut back on their medication due to no longer being eligible for free prescriptions.

Caroline Abrahams, charity director at Age UK, said: “If the government goes ahead with its proposal, it is clear that some people will be reluctant to act on symptoms or get a diagnosis, for fear they will be unable to afford long term, symptom relieving or even in some cases lifesaving medication. The government should definitely think again.”

Mark Koziol, chairman of Pharmacists' Defence Association, said: “If the prescription price becomes a barrier to accessing prescription medicines, the poorest most vulnerable members of society will be faced with the hard choice of having to decide which medication to purchase and which one/s they could “go without”. They may also try to ration items such as inhalers, rather than take them as prescribed.

He added that in the long-term the proposal would increase “workload on the NHS as a result of complications arising from poor compliance with their prescribed medications.”

More For You

Scottish community pharmacist working in high street pharmacy with supportive environment

The PDA wants investment to reach those who deliver services to patients every day

Pic credit: iStock

Funding boost in Scotland “needs to work for not just pharmacy owners but pharmacists too”, says PDA

An increase in funding for community pharmacies in Scotland needs to lead to a greater focus on supporting pharmacists rather than “simply sustain business models”, according to the Pharmacy Defence Association (PDA).

Earlier this week, Community Pharmacy Scotland (CPS) accepted the Scottish government’s initial financial offer for the 2025/26 fiscal year, securing a guaranteed minimum reimbursement of £120 million for community pharmacies — up from £110 million from 2024/25.

Keep ReadingShow less
Aspire Pharma acquisition boosts access to essential medicines for NHS patients in the UK

The acquisition is expected to further drive the company’s growth.

gettyimages

Aspire acquires UK distribution rights from Tetris

Aspire Pharma Limited, one of the UK’s fastest-growing specialty niche generics companies, has announced the acquisition of UK distribution rights to a number of products from Tetris Pharma, a subsidiary of Arecor Therapeutics.

These include products used in the treatment of bacterial infections—such as injectable and intravenous antibiotics—as well as a medicine indicated for acute myocardial infarction (MI) and deep vein thrombosis (DVT).

Keep ReadingShow less
GP surgery upgrades for annual appointments

The surgeries will have additional space to “see more patients, boost productivity and improve patient care”

Pic credit: iStock

GP surgery upgrades to create 8.3 million more annual appointments

Over 1,000 GP surgeries will have their premises modernised to meet the needs of a further 8.3 million appointments each year, the government has announced.

Backed by a cash injection of over £102 million, the surgeries will have additional space to “see more patients, boost productivity and improve patient care”.

Keep ReadingShow less
Wales boosts funding for pharmacy-led UTI and sore throat test services

The sore throat test (STTT) and treat service will be widely available

Pic credit: istock

Welsh pharmacies receive funding boost for clinical services

Two key clinical services will be available in 99 per cent of community pharmacies across Wales after a boost in funding.

The sore throat test (STTT) and treat service and the urinary tract infection (UTI) service have both benefitted from contractual negotiations between the Welsh Government and Community Pharmacy Wales (CPW).

Keep ReadingShow less
Paul Bennett
Paul Bennett, CEO, Royal Pharmaceutical Society
Paul Bennett, CEO, Royal Pharmaceutical Society

Pharmacists need to take advantage of independent prescribing pathways, says Bennett

Independent prescribing will be a “significant point” in the history of community pharmacy, according to Royal Pharmaceutical Society chief executive Paul Bennett.

Last month, the RPS announced the launch of a comprehensive new prescribing development programme to support pharmacists across all stages of their prescribing careers.

Keep ReadingShow less